Morgan Stanley Crosses and Then Falls Below 3% Threshold in Solvay Capital
The American group Morgan Stanley filed several threshold crossing declarations with Solvay between late December 2025 and mid-January 2026, according to a statement released this Monday by the Belgian chemical company.
On December 23, 2025, the American bank held no direct voting rights or any similar financial instruments. By January 9, 2026, its position was at 0.04% in direct voting rights and 3.16% through financial instruments equivalent to voting rights, totaling 3.20%. On January 12, 2026, these holdings were respectively at 0.01% and 2.77%, totaling 2.77%.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The latest notification, dated January 16, 2026, confirms the fall below the 3% threshold of direct voting rights, according to the statement. The threshold crossing in question, which occurred on January 12, 2026, resulted from either an acquisition or a disposal of shares conferring voting rights. The denominator used for the calculation is set at 105,876,416 shares.
Complete notifications as well as the detailed chain of controlled entities through which the stake is effectively held are available in the Investor Relations section of Solvay's website, the company specifies. The Belgian chemist, which reported a net profit of 4.7 billion euros in 2024, employs about 9,000 staff worldwide. The group is listed on Euronext Brussels and Paris under the ticker SOLB.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
